AstraZeneca upbeat as cancer drugs underpin sales growth : vimarsana.com

AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Shares in AstraZeneca rose 5.2% to 11,942.00 pence...

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Jeremy Cutler , Pascal Soriot , Daiichi Sankyo Co Ltd , Alliance News Ltd , Astrazeneca , Alliance News , United Kingdom Based , Rare Disease , Rare Diseases , Executive Pascal Soriot , All Rights , Markets ,